Clinical trial
Trial of 2nd Generation Anti-CEA Designer T Cells in Gastric Cancer
NCT00429078 · Roger Williams Medical Center, Other · Withdrawn
Key facts
| NCT number | NCT00429078 |
|---|---|
| Title | Trial of 2nd Generation Anti-CEA Designer T Cells in Gastric Cancer |
| Official title | Phase I Trial of 2nd Generation Anti-CEA Designer T Cells in Gastric Cancer |
| Lead sponsor | Roger Williams Medical Center, Other |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Gastric Cancer |
| Intervention type | Genetic |
| Interventions | 2nd Generation Designer T Cells |
| Enrollment | 0 |
| Start date | Jul 1, 2007 |
| Primary completion | Apr 1, 2011 |
| Completion | Apr 1, 2011 |
| First posted | Jan 31, 2007 |
| Last update posted | Mar 2, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: